DK0840748T3 - Transformerende vækstfaktor betakrystaller - Google Patents

Transformerende vækstfaktor betakrystaller

Info

Publication number
DK0840748T3
DK0840748T3 DK96927031T DK96927031T DK0840748T3 DK 0840748 T3 DK0840748 T3 DK 0840748T3 DK 96927031 T DK96927031 T DK 96927031T DK 96927031 T DK96927031 T DK 96927031T DK 0840748 T3 DK0840748 T3 DK 0840748T3
Authority
DK
Denmark
Prior art keywords
growth factor
transforming growth
tgf
factor beta
beta
Prior art date
Application number
DK96927031T
Other languages
English (en)
Inventor
Markus Gruetter
Tudor Arvinte
Peer Mittl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0840748T3 publication Critical patent/DK0840748T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
DK96927031T 1995-07-25 1996-07-17 Transformerende vækstfaktor betakrystaller DK0840748T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95810484 1995-07-25
PCT/EP1996/003140 WO1997005166A1 (en) 1995-07-25 1996-07-17 Transforming growth factor beta crystals

Publications (1)

Publication Number Publication Date
DK0840748T3 true DK0840748T3 (da) 2003-07-28

Family

ID=8221775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927031T DK0840748T3 (da) 1995-07-25 1996-07-17 Transformerende vækstfaktor betakrystaller

Country Status (12)

Country Link
US (1) US6294656B1 (da)
EP (1) EP0840748B1 (da)
JP (1) JP4246795B2 (da)
AT (1) ATE236929T1 (da)
AU (1) AU6700696A (da)
CA (1) CA2225963C (da)
DE (1) DE69627340T2 (da)
DK (1) DK0840748T3 (da)
ES (1) ES2196164T3 (da)
PT (1) PT840748E (da)
WO (1) WO1997005166A1 (da)
ZA (1) ZA966274B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6079213A (en) * 1997-12-12 2000-06-27 Magnetic Imaging Technologies Incorporated Methods of collecting, thawing, and extending the useful life of polarized gases and associated accumulators and heating jackets
US6128918A (en) * 1998-07-30 2000-10-10 Medi-Physics, Inc. Containers for hyperpolarized gases and associated methods
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
KR20050090430A (ko) 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
EP2338441B1 (en) 2003-12-11 2013-01-23 Isto Technologies Inc. Particulate cartilage system
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
CA2671925A1 (en) * 2006-12-21 2008-07-10 Stryker Corporation Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
CA2684040C (en) 2007-04-12 2016-12-06 Isto Technologies, Inc. Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126561B (de) 1960-07-05 1962-03-29 Hoechst Ag Verfahren zur Herstellung von mikrokristallinem Insulin
DE2256215C3 (de) 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
EG12098A (en) 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE2933946A1 (de) 1979-08-22 1981-03-12 Hoechst Ag, 6000 Frankfurt Insulinkristallsuspension und verfahren zu ihrer herstellung.
DE3327709A1 (de) 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3327928A1 (de) 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3606163A1 (de) 1986-02-26 1987-08-27 Hoechst Ag Vorrichtung zur applikation von arzneimittelsuspensionen
ATE101620T1 (de) 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
US5322933A (en) * 1992-05-07 1994-06-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Crystal structure of TGF-β-2
JPH08503969A (ja) 1993-09-29 1996-04-30 アルコン ラボラトリーズ,インコーポレイテッド 増殖因子と組織形成抑制剤を含有する組成物

Also Published As

Publication number Publication date
ZA966274B (en) 1997-01-27
JP4246795B2 (ja) 2009-04-02
ATE236929T1 (de) 2003-04-15
US6294656B1 (en) 2001-09-25
PT840748E (pt) 2003-08-29
JP2000502243A (ja) 2000-02-29
DE69627340T2 (de) 2004-02-05
AU6700696A (en) 1997-02-26
EP0840748A1 (en) 1998-05-13
DE69627340D1 (de) 2003-05-15
CA2225963A1 (en) 1997-02-13
ES2196164T3 (es) 2003-12-16
CA2225963C (en) 2008-02-05
EP0840748B1 (en) 2003-04-09
WO1997005166A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
DK0840748T3 (da) Transformerende vækstfaktor betakrystaller
IT1182723B (it) Tavoletta di sostanza attiva farmaceutica che si disgrega rapidamente stabili al magazzinaggio
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
NO170260C (no) Fremstilling av oksygen med hoey renhet
KR960009650B1 (en) Sustained release pharmaceutical composition of diltiazem
JO1502B1 (en) New pharmacy vehicles
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
FI890291A7 (fi) Menetelmä farmakologisesti aktiivisten aromaattisten estereiden ja tioestereiden valmistamiseksi
EP0564739A3 (da)
CA2298057A1 (en) Nucleotide analog compositions
DK680788D0 (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
IT1235356B (it) Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la contengono
ITMI921022A0 (it) Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
ATE534636T1 (de) Krystalline form ii von ritonavir enthaltende pharmazeutische zusammensetzung und ihre herstellung
EP0709395A3 (en) Preparation of Stable Insulin Analog Crystals
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
DK652988D0 (da) Anti-inflammatoriske tert-butylphenylforbindelser og farmaceutisk middel omfattende samme
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
PT86925A (pt) Process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
DE58909140D1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel.
IL106588A0 (en) Liponucleotides of seconucleosides,processes for the preparation thereof and pharmaceutical compositions with antiviral action containing them
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
HUT53355A (en) Process for producing diphenylsulfide derivatives and pharmaceutical compositions comprising such compounds as active ingredient